Rapamycin (Sirolimus): A Tracking Guide for an mTOR Inhibitor

Rapamycin, also called sirolimus, is an approved immunosuppressant used to prevent organ transplant rejection and to treat certain conditions. It is also the single most discussed off-label longevity drug, because it inhibits mTOR, a nutrient-sensing pathway whose inhibition extends lifespan in multiple animal models. In longevity circles it is usually discussed not as the daily transplant dose but as intermittent, low, weekly dosing intended to nudge the pathway without full immunosuppression.

This is an educational tracking guide, not a recommendation, and it is important to be honest about the evidence: the lifespan data is largely preclinical. Human longevity outcomes are not established.

What it is

• A macrolide that inhibits mechanistic target of rapamycin (mTOR)
• FDA-approved as an immunosuppressant, notably in transplant medicine
• Used off-label and experimentally for healthspan and aging, without approval for that use

What it does

• Inhibits mTOR complex 1, shifting cells away from growth and toward autophagy and cellular housekeeping
• Extends lifespan and healthspan in yeast, worms, flies, and mice
• Modulates the immune system, which at higher or continuous doses means immunosuppression

What the human evidence actually shows

• Robust lifespan extension exists in animal models, not in humans
• Some human work suggests intermittent low-dose rapamycin can improve immune response in older adults (rapalog studies)
• The PEARL trial studied intermittent rapamycin for aging endpoints in healthy adults; results reported it was generally well tolerated, with modest signals rather than dramatic proof of anti-aging benefit
• Bottom line: promising mechanism, thin human outcome data - treat claims of proven human life extension as unproven

Typical protocol shape

The longevity community typically discusses once-weekly oral dosing at a fraction of transplant doses, sometimes cycled with off periods, on the theory that intermittent exposure captures autophagy benefits while limiting immune suppression. This is a described pattern, not a dose recommendation, and the optimal human protocol is genuinely unknown.

What to track weekly

• Any mouth sores or canker sores, a common and dose-related side effect
• Signs of infection - slow wound healing, lingering colds, fevers
• Digestive changes and appetite

Bloodwork worth doing

• Fasting glucose and HbA1c - mTOR inhibition can worsen glucose handling in some people
• A full lipid panel - rapamycin can raise triglycerides and cholesterol
• Complete blood count to watch white cells and platelets
• Kidney and liver panels periodically

Realistic expectations

There is no felt benefit to chase day to day and no validated biomarker that confirms it is working for longevity. Anyone expecting an obvious effect will be disappointed. The honest expectation is an experimental intervention with a plausible mechanism and unproven human payoff.

Common mistakes

• Treating animal lifespan data as if it were human proof
• Ignoring lipids and glucose because the drug feels like it does nothing
• Dismissing mouth sores and recurrent infections instead of reading them as immune signals
• Combining it with other immunosuppressive factors around surgery, vaccination, or active infection

Safety notes

Rapamycin is an immunosuppressant. Real risks include impaired immune response and infection, mouth sores, elevated lipids and blood sugar, and potential interactions with many drugs, since it is metabolised through pathways affected by common medications. It should not be used around infection, surgery, or wound healing without medical input. This is an approved drug being used off-label on a longevity hypothesis that human data has not confirmed, and it warrants physician oversight and bloodwork rather than self-experimentation in the dark.

Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.